Literature DB >> 16763881

Vulnerable populations in research: the case of the seriously ill.

Philip J Nickel1.   

Abstract

This paper advances a new criterion of a vulnerable population in research. According to this criterion, there are consent-based and fairness-based reasons for calling a group vulnerable. The criterion is then applied to the case of people with serious illnesses. It is argued that people with serious illnesses meet this criterion for reasons related to consent. Seriously ill people have a susceptibility to "enticing offers" that hold out the prospect of removing or alleviating illness, and this susceptibility reduces their ability to safeguard their own interests. This explains the inclusion of people with serious illnesses in the Belmont Report's list of populations needing special protections, and supports the claim that vulnerability is the rule, rather than the exception, in biomedical research.

Entities:  

Mesh:

Year:  2006        PMID: 16763881     DOI: 10.1007/s11017-006-9000-2

Source DB:  PubMed          Journal:  Theor Med Bioeth        ISSN: 1386-7415


  14 in total

1.  The Declaration of Helsinki, CIOMS and the ethics of research on vulnerable populations.

Authors:  D Zion; L Gillam; B Loff
Journal:  Nat Med       Date:  2000-06       Impact factor: 53.440

2.  Autonomy and dependence: chronic physical illness and decision-making capacity.

Authors:  W J Dekkers
Journal:  Med Health Care Philos       Date:  2001

3.  Pharmaceutical research involving the homeless.

Authors:  Tom L Beauchamp; Bruce Jennings; Eleanor D Kinney; Robert J Levine
Journal:  J Med Philos       Date:  2002-10

4.  A critique of clinical equipoise. Therapeutic misconception in the ethics of clinical trials.

Authors:  Franklin G Miller; Howard Brody
Journal:  Hastings Cent Rep       Date:  2003 May-Jun       Impact factor: 2.683

5.  The ancillary-care responsibilities of medical researchers. An ethical framework for thinking about the clinical care that researchers owe their subjects.

Authors:  Henry S Richardson; Leah Belsky
Journal:  Hastings Cent Rep       Date:  2004 Jan-Feb       Impact factor: 2.683

6.  Therapeutic misconception and the appreciation of risks in clinical trials.

Authors:  Charles W Lidz; Paul S Appelbaum; Thomas Grisso; Michelle Renaud
Journal:  Soc Sci Med       Date:  2004-05       Impact factor: 4.634

7.  Protecting subjects who cannot give consent: toward a better standard for "minimal" risks.

Authors:  David Wendler
Journal:  Hastings Cent Rep       Date:  2005 Sep-Oct       Impact factor: 2.683

8.  False hopes and best data: consent to research and the therapeutic misconception.

Authors:  P S Appelbaum; L H Roth; C W Lidz; P Benson; W Winslade
Journal:  Hastings Cent Rep       Date:  1987-04       Impact factor: 2.683

9.  The limitations of "vulnerability" as a protection for human research participants.

Authors:  Carol Levine; Ruth Faden; Christine Grady; Dale Hammerschmidt; Lisa Eckenwiler; Jeremy Sugarman
Journal:  Am J Bioeth       Date:  2004       Impact factor: 11.229

Review 10.  The concept of vulnerability in disaster research.

Authors:  Carol Levine
Journal:  J Trauma Stress       Date:  2004-10
View more
  16 in total

1.  Rethinking the vulnerability of minority populations in research.

Authors:  Wendy Rogers; Margaret Meek Lange
Journal:  Am J Public Health       Date:  2013-10-17       Impact factor: 9.308

2.  Teaching Vulnerability in Research: A Study of Approaches Utilized by a Sample of Research Ethics Training Programs.

Authors:  Sana Loue; Bebe Loff
Journal:  J Empir Res Hum Res Ethics       Date:  2019-08-17       Impact factor: 1.742

3.  A pragmatic analysis of vulnerability in clinical research.

Authors:  David Wendler
Journal:  Bioethics       Date:  2017-09       Impact factor: 1.898

4.  Therapeutic misconception, misestimation, and optimism in participants enrolled in phase 1 trials.

Authors:  Rebecca D Pentz; Margaret White; R Donald Harvey; Zachary Luke Farmer; Yuan Liu; Colleen Lewis; Olga Dashevskaya; Taofeek Owonikoko; Fadlo R Khuri
Journal:  Cancer       Date:  2012-01-31       Impact factor: 6.860

5.  Expectations and experiences of investigators and parents involved in a clinical trial for Duchenne/Becker muscular dystrophy.

Authors:  Holly L Peay; Aad Tibben; Tyler Fisher; Ethan Brenna; Barbara B Biesecker
Journal:  Clin Trials       Date:  2013-12-04       Impact factor: 2.486

6.  Clinical trial participation as part of end-of-life cancer care: associations with medical care and quality of life near death.

Authors:  Andrea C Enzinger; Baohui Zhang; Jane C Weeks; Holly G Prigerson
Journal:  J Pain Symptom Manage       Date:  2013-10-05       Impact factor: 3.612

7.  Traditional roles in a non-traditional setting: genetic counseling in precision oncology.

Authors:  Jessica N Everett; Shanna L Gustafson; Victoria M Raymond
Journal:  J Genet Couns       Date:  2014-03-01       Impact factor: 2.537

8.  Longform recordings of everyday life: Ethics for best practices.

Authors:  Margaret Cychosz; Rachel Romeo; Melanie Soderstrom; Camila Scaff; Hillary Ganek; Alejandrina Cristia; Marisa Casillas; Kaya de Barbaro; Janet Y Bang; Adriana Weisleder
Journal:  Behav Res Methods       Date:  2020-10

9.  Ethical aspects of vulnerability in research.

Authors:  Elisabeth Weisser-Lohmann
Journal:  Poiesis Prax       Date:  2012-10-17

10.  Progression, symptoms and psychosocial concerns among those severely affected by multiple sclerosis: a mixed-methods cross-sectional study of Black Caribbean and White British people.

Authors:  Jonathan Koffman; Wei Gao; Cassie Goddard; Rachel Burman; Diana Jackson; Pauline Shaw; Fiona Barnes; Eli Silber; Irene J Higginson
Journal:  PLoS One       Date:  2013-10-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.